Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib in Malignant Peripheral Nerve Sheath Tumors
NCT00068367Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Dec 2003
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in malignant peripheral nerve sheath tumor (MPNST), sponsored by SWOG Cancer Research Network. Started Dec 2003; status: completed.
02
Drugs
erlotinib
03
Conditions
malignant peripheral nerve sheath tumor (MPNST)
Beyond the preview
Go deeper on NCT00068367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068367.